about
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.Topographic Cues Reveal Two Distinct Spreading Mechanisms in Blood Platelets.Structural basis of Na+ activation mimicry in murine thrombinCrystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1Interaction of Thrombin with Sucrose OctasulfateIntercellular Interactions as Regulators of NETosisPotent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trialPathophysiology of the antiphospholipid syndromeArf6 plays an early role in platelet activation by collagen and convulxinMolecular recognition mechanisms of thrombin.Differential signaling by protease-activated receptors: implications for therapeutic targeting.Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function.Early detection of thrombin activity in neuroinflammatory disease.Rap1b is required for normal platelet function and hemostasis in miceA blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.Engineering thrombin for selective specificity toward protein C and PAR1.Gap junctions and connexin hemichannels underpin hemostasis and thrombosis.PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.Antithrombotic and antiplatelet activities of Soshiho-tang extract.Defective platelet autocrine signaling in HPS.Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhageAcute myocardial infarction after switching from warfarin to dabigatran.Platelet activation by collagen provides sustained release of anabolic cytokines.Activated platelets in heparinized shed blood: the "second hit" of acute lung injury in trauma/hemorrhagic shock models.We can do it together: PAR1/PAR2 heterodimer signaling in VSMCsCharacterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cellsOral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.Conserved Amblyomma americanum tick Serpin19, an inhibitor of blood clotting factors Xa and XIa, trypsin and plasmin, has anti-haemostatic functions.The Interface between Inflammation and Coagulation in Cardiovascular Disease.Platelets and metastasis revisited: a novel fatty link.Emerging role of direct thrombin inhibitors in nonvalvular atrial fibrillation: potential and peril.Protease-activated receptors in cancer: A systematic review.Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patientsPrimary platelet signaling cascades and integrin-mediated signaling control ADP-ribosylation factor (Arf) 6-GTP levels during platelet activation and aggregation.Thrombin.Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.Platelet integrins and immunoreceptors.Murine platelets are not regulated by O-linked beta-N-acetylglucosamine
P2860
Q24813299-F7A5F948-9125-4AA2-8281-B795D0A92445Q27335266-94EEC557-C36A-4FD0-8FEB-8A8E26F530B7Q27644424-B8B74CEA-3400-4565-871C-0A80C6434945Q27646532-FB840889-9D24-4023-92F0-2D9D5647C852Q27660263-BE674DFD-7FA5-4BD3-98FD-0E5B9CFD6A8FQ27670722-2E3EBDAF-F17D-404E-9E35-0B1547374A45Q28078773-97F12D7A-D983-4C5C-BAD7-559BD76AAD51Q28214135-3B6DB0E0-D85B-49BB-A486-4EB2E83C446BQ28267421-FED30C3C-FE49-490E-9E90-07AD39070ABDQ30444744-54B21082-4A0B-4C37-A3E3-278FB2EE6A8CQ33221756-7410BC76-C4AF-4F34-BC53-A06656315093Q33580620-4DBB3494-0B98-4E15-B9DB-92757CCD09D9Q33624852-7F7DF361-5ABE-4076-B52D-0BDB2A7BD3A9Q33727342-FBFA613D-EAC1-4869-A58E-0BA4C8B04DA7Q33778323-985781E4-E0DD-4958-A653-D0346C19B143Q33871181-422D2F11-FDBA-4434-B4C1-A3CD140D3555Q33911257-B4474C90-8098-4A89-A11D-ACAEF15D7F61Q34243239-A638C4D7-77F7-4023-8B91-4971AB715A83Q34560212-BE12849B-3D3D-40FA-B610-65C98F66B4A4Q34775088-95E7FD06-57CF-4128-9EFB-31AAE10E7D3EQ35153196-3A21FE9F-D73F-417C-A327-E0D267E99E60Q35208004-BA928421-966C-4ED1-9BA4-314546910F54Q35211215-F745FA41-3751-4ACA-B275-6A48F4BB91F8Q35223254-BA1AC697-435B-4C95-9BC2-F08D9F1BBF7EQ35563264-E430BFCA-1CAD-4D9D-B5B8-5C150B61D634Q35599925-6443161E-29D4-4A39-8151-AAF6057207CDQ35676042-170B9399-7D6D-4F88-8D38-F459C81F4045Q35797491-EA5B20BA-679F-4D7C-B587-E63B12A81502Q35812375-FC28EDAE-7F19-4F2B-9BCC-757128B349D3Q35821321-8F6F4F9F-BEC4-4A10-8E8D-14E543834866Q35984309-3CC83BE9-43AA-45CD-8716-4C1FBABCF9F0Q36094367-FA47E821-B241-49BE-A46E-AC4C2663A63DQ36121203-F6D5286D-52CE-4B18-842E-96BC8FDD1309Q36385811-6FDE257A-55AD-4204-B850-CF5F60737BA8Q36569978-907491FE-AA5E-44A0-BB19-C175D306B5D5Q36585553-D3AA9618-A70D-4A83-88A2-1AF981E1AE35Q36800534-07CB57F3-724F-4C34-88EF-290E9827A45FQ36805883-0F0A9922-3854-4E0A-B68C-0776D5F38841Q36877378-40BD72A5-9A08-4C9D-9741-653A932AFE61Q36984274-0D7A38E6-5D86-427F-9EF5-8BDFB43D3A6D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Thrombin and platelet activation.
@ast
Thrombin and platelet activation.
@en
Thrombin and platelet activation.
@nl
type
label
Thrombin and platelet activation.
@ast
Thrombin and platelet activation.
@en
Thrombin and platelet activation.
@nl
prefLabel
Thrombin and platelet activation.
@ast
Thrombin and platelet activation.
@en
Thrombin and platelet activation.
@nl
P1433
P1476
Thrombin and platelet activation.
@en
P2093
Lawrence F Brass
P304
P356
10.1378/CHEST.124.3_SUPPL.18S
P407
P433
P577
2003-09-01T00:00:00Z